Volume 25, Number 1—January 2019
Dispatch
Dengue Virus IgM Serotyping by ELISA with Recombinant Mutant Envelope Proteins
Table 1
Dominant serotype determined by DENV serotype–specific IgM ELISA and ELISA specificity, by cohort and serotype, 2013–2018*
Cohort, DENV serotype† |
No. samples |
Dominant serotype, no. (%) samples |
Serotype specificity‡ |
|
No. samples |
% Samples (95% CI) |
|||
Returning travelers | ||||
DENV-1 | 16 | 14 (87.50) | 14 | 87.50 (61.65–98.45) |
DENV-2 | 11 | 10 (90.91) | 8 | 72.73 (39.03–93.98) |
DENV-3 | 10 | 9 (90) | 9 | 90.00 (55.50–99.75) |
DENV-4 | 8 | 8 (100.00) | 7 | 87.50 (47.35–99.68) |
All serotypes |
45 |
41 (91.11) |
38 |
84.44 (70.54–93.51) |
Residents in DENV-endemic countries | ||||
Sri Lanka | ||||
DENV-1 | 23 | 16 (69.57) | 16 | 69.57 (47.08–86.79) |
DENV-2 | 14 | 13 (92.86) | 13 | 92.86 (66.13–99.82) |
DENV-4 | 6 | 6 (100.00) | 6 | 100.00 (54.07–100.00) |
All serotypes | 43 | 35 (81.40) | 35 | 81.40 (66.60–91.61) |
Vietnam | ||||
DENV-1 | 20 | 19 (95.00) | 19 | 95.00 (75.13–99.87) |
DENV-2 | 4 | 4 (100.00) | 4 | 100.00 (39.76–100.00) |
All serotypes | 24 | 23 (95.83) | 23 | 95.83 (78.88–99.89) |
Venezuela | ||||
DENV-4 | 5 | 4 (80.00) | 4 | 80.00 (23.36–99.49) |
Brazil | ||||
DENV-4 | 2 | 2 (100.00) | 2 | 100.00 (15.81–100.00) |
Total | ||||
DENV-1 | 43 | 35 (81.40) | 35 | 81.40 (66.60–91.61) |
DENV-2 | 18 | 17 (94.44) | 17 | 94.44 (72.71–99.86) |
DENV-4 | 13 | 12 (92.31) | 12 | 92.31 (76.55–99.81) |
All serotypes |
74 |
64 (86.49) |
64 |
86.49 (76.55–93.32) |
Total, all serotypes | 119 | 105 (88.24) | 102 | 85.71 (77.12–91.45) |
*DENV, dengue virus.
†Determined by PCR.
‡Determined by correspondence with PCR results.